Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Clinical & Translational Metabolism
Erschienen in: Clinical Reviews in Bone and Mineral Metabolism 1/2019

23.11.2018 | Review Paper

Exploring the Links Between Common Diseases of Ageing—Osteoporosis, Sarcopenia and Vascular Calcification

verfasst von: Alexander J. Rodriguez, David Scott, Peter R. Ebeling

Erschienen in: Clinical & Translational Metabolism | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Vascular diseases account for a significant proportion of preventable deaths, particularly in developed countries. Our understanding of diseases that alter the structure and function of blood vessels such as vascular calcification and vascular stiffness has grown enormously such that we now appreciate them to be active processes that can be modified. Interest has also grown in examining the links between other diseases of ageing such as the loss of bone (osteoporosis) and muscle (sarcopenia) with the development and progression of vascular disease as these three disease states commonly co-occur in older age. Cardiovascular disease (including calcification and arterial stiffness) is highly prevalent in older populations and it appears that its progression is accelerated in patients with osteoporosis, fracture, sarcopenia and in those who are functionally impaired. Biological and clinical evidence supports a view that vascular disease (calcification/stiffness) may be both a cause and consequence of diseases of ageing including musculoskeletal decline. This review provides an overview of the development of vascular calcification and stiffness and explores the molecular and physiological mechanisms linking osteoporosis and sarcopenia to vascular disease development. This review also examines clinical evidence supporting the association of muscle and bone loss with vascular disease and concludes by reviewing the interventional and therapeutic potential of bone-active minerals and hormones (calcium and vitamin D) on cardiovascular disease biology, given that these represent potential interventions to target multiple body systems. Overall, this review will aim to highlight the underappreciated burden of cardiovascular disease in individuals in the context of musculoskeletal diseases.
Literatur
1.
Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002;359:1929–36.CrossRefPubMed
2.
Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999;353:878–82.CrossRefPubMed
3.
Seeman E. Invited review: pathogenesis of osteoporosis. J Appl Physiol. 2003;95(5):2142–51.CrossRefPubMed
4.
Wade SW, Strader C, Fitzpatrick LA, Anthony MS, O’Malley CD. Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporos. 2014;9(1):182.CrossRefPubMed
5.
6.
Mithal A, Bansal B, Kyer C, Ebeling P. The Asia-Pacific Regional Audit-Epidemiology, Costs, and Burden of Osteoporosis in India 2013: A Report of International Osteoporosis Foundation. Indian J Endocrinol Metab. 2014;18:449.CrossRefPubMedPubMedCentral
7.
Hernlund E, Svedbom A, Ivergård M, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8:136.CrossRefPubMedPubMedCentral
8.
Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007;22:465–75.CrossRefPubMed
9.
Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337:670–6.CrossRefPubMed
10.
Bolland MJ, Barber PA, Doughty RN, et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ. 2008;336:262–6.CrossRefPubMedPubMedCentral
11.
Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691.CrossRefPubMedPubMedCentral
12.
Licata AA. Discovery, clinical development, and therapeutic uses of bisphosphonates. Ann Pharmacother. 2005;39(4):668–77.CrossRefPubMed
13.
14.
Lacey DL, Boyle WJ, Simonet WS, Kostenuik PJ, Dougall WC, Sullivan JK, et al. Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab. Nat Rev Drug Discov. 2012;11(5):401–19.CrossRefPubMed
15.
Satterwhite J, Heathman M, Miller PD, Marín F, Glass EV, Dobnig H. Pharmacokinetics of teriparatide (rhPTH[1-34]) and calcium pharmacodynamics in postmenopausal women with osteoporosis. Calcif Tissue Int. 2010;87:485–92.CrossRefPubMedPubMedCentral
16.
Brixen KT, Christensen B, Ejersted C, Langdahl BL. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis. Pharmacol Toxicol. 2004;94(6):260–70.CrossRef
17.
Brennan T, Rybchyn M, Green W, Atwa S, Conigrave A, Mason R. Osteoblasts play key roles in the mechanisms of action of strontium ranelate. Br J Pharmacol. 2009;157:1291–300.CrossRefPubMedPubMedCentral
18.
19.
20.
Nguyen TV, Eisman JA. Fracture risk assessment: from population to individual. J Clin Densitom. 2017;20:368–78.CrossRefPubMed
21.
22.
Kerckhofs G, Durand M, Vangoitsenhoven R, Marin C, van der Schueren B, Carmeliet G, et al. Changes in bone macro- and microstructure in diabetic obese mice revealed by high resolution microfocus X-ray computed tomography. Sci Rep. 2016;6(1):35517.CrossRefPubMedPubMedCentral
23.
Liu C-T, Broe KE, Zhou Y, Boyd SK, Cupples LA, Hannan MT, et al. Visceral adipose tissue is associated with bone microarchitecture in the Framingham osteoporosis study. J Bone Miner Res. 2017;32(1):143–50.CrossRefPubMed
24.
Nielson CM, Srikanth P, Orwoll ES. Obesity and fracture in men and women: an epidemiologic perspective. J Bone Miner Res. 2012;27:1–10.CrossRefPubMed
25.
Marcus RL, Addison O, Kidde JP, Dibble LE, Lastayo PC. Skeletal muscle fat infiltration: impact of age, inactivity, and exercise. J Nutr Health Aging. 2010;14:362–6.CrossRefPubMedPubMedCentral
26.
Scott D, Shore-Lorenti C, McMillan LB, et al. Calf muscle density is independently associated with physical function in overweight and obese older adults. J Musculoskelet Neuronal Interact. 2018;18:9–17.PubMedPubMedCentral
27.
Scott D, Shore-Lorenti C, McMillan L, et al. Associations of components of sarcopenic obesity with bone health and balance in older adults. Arch Gerontol Geriatr. 2018;75:125–31.CrossRefPubMed
28.
Szulc P, Samelson EJ, Kiel DP, Delmas PD. Increased bone resorption is associated with increased risk of cardiovascular events in men: the MINOS study. J Bone Miner Res. 2009;24:2023–31.CrossRefPubMedPubMedCentral
29.
Yang S, Chen A, Wu T. Association of history of fracture with prehypertension and hypertension: a retrospective case-control study. BMC Musculoskelet Disord. 2015;16:86.CrossRefPubMedPubMedCentral
30.
Sennerby U, Melhus H, Gedeborg R, et al. Cardiovascular diseases and risk of hip fracture. JAMA. 2009;302:1666.CrossRefPubMed
31.
Fricke O, Beccard R, Semler O, Schoenau E. Analyses of muscular mass and function: the impact on bone mineral density and peak muscle mass. Pediatr Nephrol. 2010;25:2393–400.CrossRefPubMed
32.
Tsuda K, Nishio I, Masuyama Y. Bone mineral density in women with essential hypertension. Am J Hypertens. 2001;14:704–7.CrossRefPubMed
33.
Jorgensen L, Joakimsen O, Rosvold Berntsen GK, Heuch I, Jacobsen BK. Low bone mineral density is related to echogenic carotid artery plaques: a population-based study. Am J Epidemiol. 2004;160:549–56.CrossRefPubMed
34.
Tanko LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res. 2005;20(11):1912–20.CrossRefPubMed
35.
Wong CX, Gan SW, Lee SW, et al. Atrial fibrillation and risk of hip fracture: a population-based analysis of 113,600 individuals. Int J Cardiol. 2017;243:229–32.CrossRefPubMed
36.
Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA. High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet. 1999;354:971–5.CrossRefPubMed
37.
Sennerby U, Farahmand B, Ahlbom A, Ljunghall S, Michaelsson K. Cardiovascular diseases and future risk of hip fracture in women. Osteoporos Int. 2007;18:1355–62.CrossRefPubMed
38.
Bagger YZ, Tanko LB, Alexandersen P, Qin G, Christiansen C. Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip. J Intern Med. 2006;259:598–605.CrossRefPubMed
39.
Jorgensen L, Joakimsen O, Mathiesen EB, et al. Carotid plaque echogenicity and risk of nonvertebral fractures in women: a longitudinal population-based study. Calcif Tissue Int. 2006;79:207–13.CrossRefPubMed
40.
Scott D, Blizzard L, Fell J, Jones G. The epidemiology of sarcopenia in community living older adults: what role does lifestyle play? J Cachexia Sarcopenia Muscle. 2011;2(3):125–34.CrossRefPubMedPubMedCentral
41.
Bischoff-Ferrari HA, Orav JE, Kanis JA, et al. Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int. 2015;26:2793–802.CrossRefPubMed
42.
Patel HP, Syddall HE, Jameson K, Robinson S, Denison H, Roberts HC, et al. Prevalence of sarcopenia in community-dwelling older people in the UK using the European working group on sarcopenia in older people (EWGSOP) definition: findings from the Hertfordshire cohort study (HCS). Age Ageing. 2013;42(3):378–84.CrossRefPubMedPubMedCentral
43.
Yamada M, Nishiguchi S, Fukutani N, et al. Prevalence of sarcopenia in community-dwelling Japanese older adults. J Am Med Dir Assoc. 2013;14:911–5.CrossRefPubMed
44.
Waters DL, Baumgartner RN, Garry PJ. Sarcopenia: current perspectives. J Nutr Health Aging. 2000;4:133–9.PubMed
45.
Delmonico MJ, Harris TB, Visser M, Park SW, Conroy MB, Velasquez-Mieyer P, et al. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr. 2009;90(6):1579–85.CrossRefPubMedPubMedCentral
46.
Miljkovic I, Kuipers AL, Cauley JA, et al. Greater skeletal muscle fat infiltration is associated with higher all-cause and cardiovascular mortality in older men. J Gerontol A Biol Sci Med Sci. 2015;70:1133–40.CrossRefPubMedPubMedCentral
47.
Scott D, Trbojevic T, Skinner E, Clark RA, Levinger P, Haines TP, et al. Associations of calf inter- and intra-muscular adipose tissue with cardiometabolic health and physical function in community-dwelling older adults. J Musculoskelet Neuronal Interact. 2015;15(4):350–7.PubMedPubMedCentral
48.
Rosique-Esteban N, Babio N, Díaz-López A, et al. Leisure-time physical activity at moderate and high intensity is associated with parameters of body composition, muscle strength and sarcopenia in aged adults with obesity and metabolic syndrome from the PREDIMED-Plus study. Clin Nutr. 2018; published online June 6. https://​doi.​org/​10.​1016/​j.​clnu.​2018.​05.​023.
49.
Kim J, Lee Y, Kye S, Chung Y-S, Kim K-M. Association between healthy diet and exercise and greater muscle mass in older adults. J Am Geriatr Soc. 2015;63:886–92.CrossRefPubMed
50.
Reid KF, Martin KI, Doros G, et al. Comparative effects of light or heavy resistance power training for improving lower extremity power and physical performance in mobility-limited older adults. J Gerontol A Biol Sci Med Sci. 2015;70:374–80.CrossRefPubMed
51.
PETERSON MD, SEN A, GORDON PM. Influence of resistance exercise on lean body mass in aging adults. Med Sci Sport Exerc. 2011;43:249–58.CrossRef
52.
Campbell WW, Trappe TA, Wolfe RR, Evans WJ. The recommended dietary allowance for protein may not be adequate for older people to maintain skeletal muscle. J Gerontol A Biol Sci Med Sci. 2001;56:M373–80.CrossRefPubMed
53.
Morris MS, Jacques PF. Total protein, animal protein and physical activity in relation to muscle mass in middle-aged and older Americans. Br J Nutr. 2013;109:1294–303.CrossRefPubMed
54.
55.
Gonzalez-Freire M, de Cabo R, Studenski SA, Ferrucci L. The neuromuscular junction: aging at the crossroad between nerves and muscle. Front Aging Neurosci. 2014;6:208.CrossRefPubMedPubMedCentral
56.
Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JAE, et al. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev. 2012;33(3):456–92.CrossRefPubMedPubMedCentral
57.
Scott D, Blizzard L, Fell J, Giles G, Jones G. Associations between dietary nutrient intake and muscle mass and strength in community-dwelling older adults: the Tasmanian older adult cohort study. J Am Geriatr Soc. 2010;58:2129–34.CrossRefPubMed
58.
Rousseau A-F, Foidart-Desalle M, Ledoux D, Remy C, Croisier JL, Damas P, et al. Effects of cholecalciferol supplementation and optimized calcium intakes on vitamin D status, muscle strength and bone health: a one-year pilot randomized controlled trial in adults with severe burns. Burns. 2015;41(2):317–25.CrossRefPubMed
59.
van Dronkelaar C, van Velzen A, Abdelrazek M, van der Steen A, Weijs PJM, Tieland M. Minerals and Sarcopenia; The Role of Calcium, Iron, Magnesium, Phosphorus, Potassium, Selenium, Sodium, and Zinc on Muscle Mass, Muscle Strength, and Physical Performance in Older Adults: A Systematic Review. J Am Med Dir Assoc. 2018;19:6–11.e3.CrossRefPubMed
60.
61.
Bauer JM, Verlaan S, Bautmans I, et al. Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc. 2015;16:740–7.CrossRefPubMed
62.
Beaudart C, Dawson A, Shaw SC, et al. Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporos Int. 2017;28:1817–33.CrossRefPubMedPubMedCentral
63.
Antoniak AE, Greig CA. The effect of combined resistance exercise training and vitamin D 3 supplementation on musculoskeletal health and function in older adults: a systematic review and meta-analysis. BMJ Open. 2017;7:e014619.CrossRefPubMedPubMedCentral
64.
Trajanoska K, Schoufour JD, Darweesh SK, et al. Sarcopenia and its clinical correlates in the general population: the Rotterdam study. J Bone Miner Res. 2018;33:1209–18.CrossRefPubMed
65.
Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee SG. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc. 2014;62:253–60.CrossRefPubMed
66.
Chuang S-Y, Chang H-Y, Lee M-S, Chia-Yu Chen R, Pan W-H. Skeletal muscle mass and risk of death in an elderly population. Nutr Metab Cardiovasc Dis. 2014;24:784–91.CrossRefPubMed
67.
68.
69.
Tsamis A, Krawiec JT, Vorp DA. Elastin and collagen fibre microstructure of the human aorta in ageing and disease: a review. J R Soc Interface. 2013;10:20121004.CrossRefPubMedPubMedCentral
70.
Speer MY, Yang H-Y, Brabb T, et al. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res. 2009;104:733–41.CrossRefPubMedPubMedCentral
71.
Zhu D, Mackenzie NCW, Millán JL, Farquharson C, MacRae VE. The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS One. 2011;6:e19595.CrossRefPubMedPubMedCentral
72.
73.
74.
Ooshima A, Fuller GC, Cardinale GJ, Spector S, Udenfriend S. Increased collagen synthesis in blood vessels of hypertensive rats and its reversal by antihypertensive agents. Proc Natl Acad Sci U S A. 1974;71:3019–23.CrossRefPubMedPubMedCentral
75.
Shang X, Scott D, Hodge A, et al. Adiposity assessed by anthropometric measures has a similar or greater predictive ability than dual-energy X-ray absorptiometry measures for abdominal aortic calcification in community-dwelling older adults. Int J Card Imaging. 2016;32:1451–60.CrossRef
76.
Norman PE, Jamrozik K, Lawrence-Brown MM, et al. Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ. 2004;329:1259.CrossRefPubMedPubMedCentral
77.
Murphy WA, Zur ND, Gostner P, Knapp R, Recheis W, Seidler H. The Iceman: Discovery and Imaging. Radiology. 2003;226:614–29.CrossRefPubMed
78.
Virchow R. Cellular pathology. As based upon physiological and pathological histology. Lecture XVI--atheromatous affection of arteries. 1858. Nutr Rev. 1989;47:23–5.CrossRefPubMed
79.
Lehto S, Niskanen L, Suhonen M, Rönnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1996;16:978–83.CrossRefPubMed
80.
Lewis JR, Schousboe JT, Lim WH, Wong G, Zhu K, Lim EM, et al. Abdominal aortic calcification identified on lateral spine images from bone densitometers are a marker of generalized atherosclerosis in elderly women. Arterioscler Thromb Vasc Biol. 2016;36(1):166–73.CrossRefPubMed
81.
82.
Ishii T, Asuwa N. Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection. Hum Pathol. 2000;31:640–6.CrossRefPubMed
83.
84.
Loree HM, Tobias BJ, Gibson LJ, Kamm RD, Small DM, Lee RT. Mechanical properties of model atherosclerotic lesion lipid pools. Arterioscler Thromb. 1994;14:230–4.CrossRefPubMed
85.
Cho I-J, Chang H-J, Park H-B, et al. Aortic calcification is associated with arterial stiffening, left ventricular hypertrophy, and diastolic dysfunction in elderly male patients with hypertension. J Hypertens. 2015;33:1633–41.CrossRefPubMed
86.
87.
Guo J, Fujiyoshi A, Willcox B, et al. Increased Aortic Calcification Is Associated With Arterial Stiffness Progression in Multiethnic Middle-Aged Men. Hypertension. 2017;69:102–8.CrossRefPubMed
88.
Chien S. Mechanotransduction and endothelial cell homeostasis: the wisdom of the cell. Am J Physiol Heart Circ Physiol. 2007;292:H1209–24.CrossRefPubMed
89.
Yang JW, Cho KI, Kim JH, et al. Wall shear stress in hypertensive patients is associated with carotid vascular deformation assessed by speckle tracking strain imaging. Clin Hypertens. 2014;20:10.CrossRefPubMedPubMedCentral
90.
Nicoll R, Henein M. Arterial calcification: a new perspective? Int J Cardiol. 2017;228:11–22.CrossRefPubMed
91.
Schousboe JT, Taylor BC, Kiel DP, Ensrud KE, Wilson KE, McCloskey EV. Abdominal aortic calcification detected on lateral spine images from a bone densitometer predicts incident myocardial infarction or stroke in older women. J Bone Miner Res. 2008;23(3):409–16.CrossRefPubMed
92.
Kauppila LI, Polak JF, Cupples LA, Hannan MT, Kiel DP, Wilson PW. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis. 1997;132:245–50.CrossRefPubMed
93.
Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–41.CrossRefPubMed
94.
Hametner B, Wassertheurer S, Kropf J, Mayer C, Eber B, Weber T. Oscillometric estimation of aortic pulse wave velocity. Blood Press Monit. 2013;18:173–6.CrossRefPubMed
95.
Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–605.CrossRefPubMed
96.
97.
Witteman JM, Kok F, Van Saase JCM, Valkenburg H. Aortic calcification as a predictor of cardiovascular mortality. Lancet. 1986;328:1120–2.CrossRef
98.
Nielsen ML, Pareek M, Gerke O, et al. Uncontrolled hypertension is associated with coronary artery calcification and electrocardiographic left ventricular hypertrophy: a case-control study. J Hum Hypertens. 2015;29:303–8.CrossRefPubMed
99.
Issever AS, Kentenich M, Kohlitz T, Diederichs G, Zimmermann E. Osteoporosis and atherosclerosis: a post-mortem MDCT study of an elderly cohort. Eur Radiol. 2013;23(10):2823–9.CrossRefPubMed
100.
Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O’Donnell CJ, Wilson PW. Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham heart study. [erratum appears in Calcif tissue Int. 2004 Feb;74(2):208]. Calcif Tissue Int. 2001;68:271–6.CrossRefPubMed
101.
Cai T, Sun D, Duan Y, Wen P, Dai C, Yang J, et al. WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression. Exp Cell Res. 2016;345(2):206–17.CrossRefPubMed
102.
Vega OA, Lucero CMJ, Araya HF, et al. Wnt/β-catenin signaling activates expression of the bone-related transcription factor RUNX2 in select human osteosarcoma cell types. J Cell Biochem. 2017;118:3662–74.CrossRefPubMed
103.
Shi L, Cai G, Shi J, et al. Ossification of the posterior ligament is mediated by osterix via inhibition of the β-catenin signaling pathway. Exp Cell Res. 2016;349:53–9.CrossRefPubMed
104.
Moon YJ, Yun C-Y, Lee J-C, Kim JR, Park B-H, Cho E-S. Maturation of cortical bone suppresses periosteal osteoprogenitor proliferation in a paracrine manner. J Mol Histol. 2016;47:445–53.CrossRefPubMed
105.
Kook S-H, Heo JS, Lee J-C. Crucial roles of canonical Runx2-dependent pathway on Wnt1-induced osteoblastic differentiation of human periodontal ligament fibroblasts. Mol Cell Biochem. 2015;402:213–23.CrossRefPubMed
106.
Yu S, Yerges-Armstrong LM, Chu Y, Zmuda JM, Zhang Y. AP2 suppresses osteoblast differentiation and mineralization through down-regulation of Frizzled-1. Biochem J. 2015;465:395–404.CrossRefPubMed
107.
Yuan L-Q, Zhu J-H, Wang H-W, et al. RANKL is a downstream mediator for insulin-induced osteoblastic differentiation of vascular smooth muscle cells. PLoS One. 2011;6:e29037.CrossRefPubMedPubMedCentral
108.
Malyankar UM, Scatena M, Suchland KL, Yun TJ, Clark EA, Giachelli CM. Osteoprotegerin is an α v β 3 -induced, NF-κB-dependent survival factor for endothelial cells. J Biol Chem. 2000;275:20959–62.CrossRefPubMed
109.
110.
Zhang K, Zhang Y, Feng W, et al. Interleukin-18 Enhances Vascular Calcification and Osteogenic Differentiation of Vascular Smooth Muscle Cells Through TRPM7 Activation. Arterioscler Thromb Vasc Biol. 2017;37(10):1933–43.CrossRefPubMed
111.
Cosman F, Crittenden DB, Adachi JD, et al. Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med. 2016;375:1532–43.CrossRefPubMed
112.
Lewiecki EM, Blicharski T, Goemaere S, Lippuner K, Meisner PD, Miller PD, et al. A phase III randomized placebo-controlled trial to evaluate efficacy and safety of Romosozumab in men with osteoporosis. J Clin Endocrinol Metab. 2018;103(9):3183–93.CrossRefPubMed
113.
Touw WA, Ueland T, Bollerslev J, Schousboe JT, Lim WH, Wong G, et al. Association of Circulating Wnt Antagonists with Severe Abdominal Aortic Calcification in elderly women. J Endocr Soc. 2017;1(1):26–38.CrossRefPubMedPubMedCentral
114.
Hampson G, Edwards S, Conroy S, Blake GM, Fogelman I, Frost ML. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women. Bone. 2013;56:42–7.CrossRefPubMed
115.
Krishna SM, Seto S-W, Jose RJ, et al. Wnt signaling pathway inhibitor Sclerostin inhibits angiotensin II–induced aortic aneurysm and AtherosclerosisHighlights. Arterioscler Thromb Vasc Biol. 2017;37:553–66.CrossRefPubMed
116.
Acıbucu F, Dokmetas H, Acıbucu D, Kılıclı F, Aydemir M, Cakmak E. Effect of vitamin D treatment on serum Sclerostin level. Exp Clin Endocrinol Diabetes. 2017;125:634–7.CrossRefPubMed
117.
Sankaralingam A, Roplekar R, Turner C, Dalton RN, Hampson G. Changes in Dickkopf-1 (DKK1) and Sclerostin following a loading dose of vitamin D 2 (300,000 IU). J Osteoporos. 2014;2014:682763.CrossRefPubMedPubMedCentral
118.
Breslavsky A, Frand J, Matas Z, Boaz M, Barnea Z, Shargorodsky M. Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr. 2013;32:970–5.CrossRefPubMed
119.
Larsen T, Mose FH, Bech JN, Hansen AB, Pedersen EB. Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens. 2012;25:1215–22.CrossRefPubMed
120.
Dreyer G, Tucker AT, Harwood SM, Pearse RM, Raftery MJ, Yaqoob MM. Ergocalciferol and microcirculatory function in chronic kidney disease and concomitant vitamin D deficiency: an exploratory, double blind, Randomised Controlled Trial. PLoS One. 2014;9:e99461.CrossRefPubMedPubMedCentral
121.
Rejnmark L, Bislev LS, Cashman KD, et al. Non-skeletal health effects of vitamin D supplementation: a systematic review on findings from meta-analyses summarizing trial data. PLoS One. 2017;12:e0180512.CrossRefPubMedPubMedCentral
122.
Sambrook PN, Chen JS, Simpson JM, March LM. Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality. Med J Aust. 2010;193(3):154–6.PubMed
123.
Kranenburg G, Bartstra JW, Weijmans M, et al. Bisphosphonates for cardiovascular risk reduction: a systematic review and meta-analysis. Atherosclerosis. 2016;252:106–15.CrossRefPubMed
124.
Kawahara T, Nishikawa M, Kawahara C, Inazu T, Sakai K, Suzuki G. Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial. Circulation. 2013;127:2327–35.CrossRefPubMed
125.
Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG. Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial. Am J Kidney Dis. 2010;56:57–68.CrossRefPubMed
126.
Cummings SR, Martin JS, McClung MR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361:756–65.CrossRefPubMed
127.
Samelson EJ, Miller PD, Christiansen C, et al. RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk. J Bone Miner Res. 2014;29:450–7.CrossRefPubMed
128.
Ueki K, Yamada S, Tsuchimoto A, et al. Rapid progression of vascular and soft tissue calcification while being managed for severe and persistent hypocalcemia induced by Denosumab treatment in a patient with multiple myeloma and chronic kidney disease. Intern Med. 2015;54:2637–42.CrossRefPubMed
129.
Scott D, Blizzard L, Fell J, Jones G. Prospective associations between ambulatory activity, body composition and muscle function in older adults. Scand J Med Sci Sports. 2011;21:e168–75.CrossRefPubMed
130.
Tarantino G, Costantini S, Finelli C, et al. Is serum Interleukin-17 associated with early atherosclerosis in obese patients? J Transl Med. 2014;12:214.CrossRefPubMedPubMedCentral
131.
Alexandersen P, Tankó LB, Bagger YZ, Jespersen J, Skouby SO, Christiansen C. Associations between aortic calcification and components of body composition in elderly men*. Obesity. 2006;14:1571–8.CrossRefPubMed
132.
Szulc P, Hofbauer LC, Rauner M, Goettsch C, Chapurlat R, Schoppet M. Serum myostatin levels are negatively associated with abdominal aortic calcification in older men: the STRAMBO study. Eur J Endocrinol. 2012;167:873–80.CrossRefPubMed
133.
Jensky NE, Allison MA, Loomba R, et al. Null association between abdominal muscle and calcified atherosclerosis in community-living persons without clinical cardiovascular disease: the multi-ethnic study of atherosclerosis. Metabolism. 2013;62:1562–9.CrossRefPubMed
134.
Idoate F, Cadore EL, Casas-Herrero A, et al. Adipose tissue compartments, muscle mass, muscle fat infiltration, and coronary calcium in institutionalized frail nonagenarians. Eur Radiol. 2015;25:2163–75.CrossRefPubMed
135.
Wassel CL, Laughlin GA, Saad SD, Araneta MRG, Wooten W, Barrett-Connor E, et al. Associations of abdominal muscle area with 4-year change in coronary artery calcium differ by ethnicity among post-menopausal women. Ethn Dis. 2015;25(4):435–42.CrossRefPubMedPubMedCentral
136.
Ko B-J, Chang Y, Jung H-S, et al. Relationship between low relative muscle mass and coronary artery calcification in healthy AdultsSignificance. Arterioscler Thromb Vasc Biol. 2016;36:1016–21.CrossRefPubMed
137.
Idoate F, Cadore EL, Casas-Herrero A, et al. Noncoronary vascular calcification, bone mineral density, and muscle mass in institutionalized frail nonagenarians. Rejuvenation Res. 2017;20:298–308.CrossRefPubMed
138.
Spahillari A, Mukamal KJ, DeFilippi C, et al. The association of lean and fat mass with all-cause mortality in older adults: the cardiovascular health study. Nutr Metab Cardiovasc Dis. 2016;26:1039–47.CrossRefPubMedPubMedCentral
139.
Chuang S-Y, Hsu Y-Y, Chen RC-Y, Liu W-L, Pan W-H. Abdominal obesity and low skeletal muscle mass jointly predict Total mortality and cardiovascular mortality in an elderly Asian population. J Gerontol A Biol Sci Med Sci. 2016;71(8):1049–55.CrossRefPubMed
140.
Elliott B, Renshaw D, Getting S, Mackenzie R. The central role of myostatin in skeletal muscle and whole body homeostasis. Acta Physiol. 2012;205:324–40.CrossRef
141.
Hamrick MW, Shi X, Zhang W, Pennington C, Thakore H, Haque M, et al. Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading. Bone. 2007;40(6):1544–53.CrossRefPubMedPubMedCentral
142.
Artaza JN, Singh R, Ferrini MG, Braga M, Tsao J, Gonzalez-Cadavid NF. Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts. J Endocrinol. 2008;196:235–49.CrossRefPubMed
143.
Saely CH, Dyballa T, Vonbank A, et al. Type 2 diabetes but not coronary atherosclerosis is an independent determinant of impaired mobility in angiographied coronary patients. Diabetes Res Clin Pract. 2008;82:185–9.CrossRefPubMed
144.
Abizanda Soler P, Paterna Mellinas G, Martín Sebastiá E, Casado Moragón L, López Jiménez E, Martínez SE. Aterosclerosis subclínica, un predictor de limitación funcional al año en ancianos con alto nivel funcional: estudio Albacete. Rev Esp Geriatr Gerontol. 2010;45:125–30.CrossRefPubMed
145.
Den Ouden MEM, Schuurmans MJ, Arts EMA, et al. Atherosclerosis and physical functioning in older men, a longitudinal study. J Nutr Health Aging. 2013;17:97–104.CrossRef
146.
Park J, Park H. Muscle strength and carotid artery flow velocity is associated with increased risk of atherosclerosis in adults. Cardiol J. 2017;24:385–92.CrossRefPubMed
147.
Shimizu Y, Sato S, Koyamatsu J, et al. Handgrip strength and subclinical carotid atherosclerosis in relation to platelet levels among hypertensive elderly Japanese. Oncotarget. 2017;8:69362–9.PubMedPubMedCentral
148.
Suwa M, Imoto T, Kida A, Yokochi T, Iwase M, Kozawa K. Association of body flexibility and carotid atherosclerosis in Japanese middle-aged men: a cross-sectional study. BMJ Open. 2018;8:e019370.CrossRefPubMedPubMedCentral
149.
Everson-Rose SA, Mendes de Leon CF, Roetker NS, Lutsey PL, Alonso A. Subclinical cardiovascular disease and changes in self-reported mobility: multi-ethnic study of atherosclerosis. Journals Gerontol A Biol Sci Med Sci. 2018;73:218–24.CrossRef
150.
Jadczak AD, Makwana N, Luscombe-Marsh N, Visvanathan R, Schultz TJ. Effectiveness of exercise interventions on physical function in community-dwelling frail older people. JBI Database System Rev Implement Rep. 2018;16:752–75.CrossRefPubMed
151.
Lai C-C, Tu Y-K, Wang T-G, Huang Y-T, Chien K-L. Effects of resistance training, endurance training and whole-body vibration on lean body mass, muscle strength and physical performance in older people: a systematic review and network meta-analysis. Age Ageing. 2018;47(3):367–73.CrossRefPubMed
152.
Rossow LM, Fahs CA, Thiebaud RS, et al. Arterial stiffness and blood flow adaptations following eight weeks of resistance exercise training in young and older women. Exp Gerontol. 2014;53:48–56.CrossRefPubMed
153.
Shiotsu Y, Watanabe Y, Tujii S, Yanagita M. Effect of exercise order of combined aerobic and resistance training on arterial stiffness in older men. Exp Gerontol. 2018;111:27–34.CrossRefPubMed
154.
Green D, Cheetham C, Mavaddat L, Watts K, Best M, Taylor R, et al. Effect of lower limb exercise on forearm vascular function: contribution of nitric oxide. Am J Physiol Heart Circ Physiol. 2002;283(3):H899–907.CrossRefPubMed
155.
Endes S, Schaffner E, Caviezel S, et al. Long-term physical activity is associated with reduced arterial stiffness in older adults: longitudinal results of the SAPALDIA cohort study. Age Ageing. 2016;45:110–5.CrossRefPubMed
156.
Wildman RP, Mackey RH, Bostom A, Thompson T, Sutton-Tyrrell K. Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension. 2003;42:468–73.CrossRefPubMed
157.
Jarrell JC, Morin J, Vasquez K, Cuneo GJ, Kossodo S, Peterson JD. Imaging of Cathepsin K activity in rodent models of bone turnover and soft tissue calcification. Mol Imaging Biol. 2012;1:S1741.
158.
Shanbhogue VV, Støving RK, Frederiksen KH, Hanson S, Brixen K, Gram J, et al. Bone structural changes after gastric bypass surgery evaluated by HR-pQCT: a two-year longitudinal study. Eur J Endocrinol. 2017;176(6):685–93.CrossRefPubMedPubMedCentral
159.
Szulc P, Schoppet M, Goettsch C, et al. Endocrine and clinical correlates of Myostatin serum concentration in men—the STRAMBO study. J Clin Endocrinol Metab. 2012;97:3700–8.CrossRefPubMed
160.
Aihara K, Azuma H, Akaike M, et al. Disruption of nuclear vitamin D receptor gene causes enhanced Thrombogenicity in mice. J Biol Chem. 2004;279:35798–802.CrossRefPubMed
161.
Chen S, Law CS, Grigsby CL, et al. Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac HypertrophyClinical perspective. Circulation. 2011;124:1838–47.CrossRefPubMedPubMedCentral
162.
163.
Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Korfer R, Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol. 2003;41:105–12.CrossRefPubMed
164.
Al Mheid I, Patel R, Murrow J, et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol. 2011;58:186–92.CrossRefPubMedPubMedCentral
165.
Tomson J, Hin H, Emberson J, et al. Effects of vitamin D on blood pressure, arterial stiffness, and cardiac function in older people after 1 year: BEST-D (biochemical efficacy and safety trial of vitamin D). J Am Heart Assoc. 2017;6:e005707.CrossRefPubMedPubMedCentral
166.
Sluyter JD, Camargo CA, Stewart AW, et al. Effect of monthly, high-dose, Long-Term Vitamin D Supplementation on Central Blood Pressure Parameters: A Randomized Controlled Trial Substudy. J Am Heart Assoc. 2017;6:e006802.CrossRefPubMedPubMedCentral
167.
Witte KK, Byrom R, Gierula J, et al. Effects of vitamin D on cardiac function in patients with chronic HF: the VINDICATE study. J Am Coll Cardiol. 2016;67:2593–603.CrossRefPubMedPubMedCentral
168.
Chung M, Tang AM, Fu Z, Wang DD, Newberry SJ. Calcium intake and cardiovascular disease risk. Ann Intern Med. 2016;165:856.CrossRefPubMed
169.
Reid IR, Gamble GD, Bolland MJ. Circulating calcium concentrations, vascular disease and mortality: a systematic review. J Intern Med. 2016;279(6):524–40.CrossRefPubMed
170.
Harvey NC, Biver E, Kaufman J-M, Bauer J, Branco J, Brandi ML, et al. The role of calcium supplementation in healthy musculoskeletal ageing. Osteoporos Int. 2017;28(2):447–62.CrossRefPubMed
171.
Michaelsson K, Melhus H, Warensjo Lemming E, Wolk A, Byberg L. Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. BMJ. 2013;346:f228.CrossRefPubMedPubMedCentral
172.
Khan B, Nowson CA, Daly RM, et al. Higher dietary calcium intakes are associated with reduced risks of fractures, cardiovascular events, and mortality: a prospective cohort study of older men and women. J Bone Miner Res. 2015;30:1758–66.CrossRefPubMed
173.
Kim JH, Yoon JW, Kim KW, et al. Increased dietary calcium intake is not associated with coronary artery calcification. Int J Cardiol. 2012;157:429–31.CrossRefPubMed
174.
Anderson JJB, Kruszka B, Delaney JAC, et al. Calcium intake from diet and supplements and the risk of coronary artery calcification and its progression among older adults: 10-year follow-up of the multi-ethnic study of atherosclerosis (MESA). J Am Heart Assoc. 2016;5:e003815.CrossRefPubMedPubMedCentral
Metadaten
Titel
Exploring the Links Between Common Diseases of Ageing—Osteoporosis, Sarcopenia and Vascular Calcification
verfasst von
Alexander J. Rodriguez
David Scott
Peter R. Ebeling
Publikationsdatum
23.11.2018
Verlag
Springer US
Erschienen in
Clinical & Translational Metabolism / Ausgabe 1/2019
Print ISSN: 1534-8644
Elektronische ISSN: 2948-2445
DOI
https://doi.org/10.1007/s12018-018-9251-2

Weitere Artikel der Ausgabe 1/2019

Clinical Reviews in Bone and Mineral Metabolism 1/2019 Zur Ausgabe

Review Paper

The Clinical Relevance of the Bone Vascular System: Age-Related Implications

Review Paper

Fourier Transform Infrared Spectroscopy of Bone Tissue: Bone Quality Assessment in Preclinical and Clinical Applications of Osteoporosis and Fragility Fracture

Review Paper

Effects of Sympathetic Activity on Human Skeletal Homeostasis: Clinical Evidence from Pheochromocytoma

ACKNOWLEDGEMENT TO REFEREES

Acknowledgement to Referees 2018

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Krebspatienten impfen: Was? Wen? Und wann nicht?

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Nierenultraschall: Tipps vom Profi

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

„KI sieht, was wir nicht sehen“
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise